Skip to main content
. 2022 Aug 11;13:974416. doi: 10.3389/fgene.2022.974416

FIGURE 7.

FIGURE 7

CD8A as a therapeutic biomarker indicating multiple anti-tumor agents’ responsiveness on various cancer cell lines, and cancer cohorts (A) Associations between CD8A expression, and 50% inhibitory concentration (IC50) values of varying antitumor agents or compounds in tumor cell lines based on GDSC and CTRP databases (B) Associations between the expression levels of CD8A, and therapeutic responses to various antitumor drugs in clinical cancer cohorts.